Arbutus Biopharma financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

아버터스 바이오파머NASDAQ:ABUS · Nasdaq · Healthcare

$4.67+4.94%

2026-10-05 close · prelim

Arbutus Biopharma's published financial data is dated 2026-10-04. 2024 revenue was $6M. 2024 operating profit was −$76M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy